?:authorAffiliation
|
-
[\'Department of Refractory Viral Infections, National Center for Global Health and Medicine (NCGM) Research Institute, Tokyo, Japan. kmaeda@ri.ncgm.go.jp.\', \'Department of Clinical Sciences, Kumamoto University Hospital, Kumamoto, Japan.\', \'Center of Clinical Sciences, NCGM, Tokyo, Japan.\', \'AIDS Clinical Center, NCGM, Tokyo, Japan.\', \'Sysmex Corporation, Hyogo, Japan.\', \'Department of Refractory Viral Infections, National Center for Global Health and Medicine (NCGM) Research Institute, Tokyo, Japan.\', \'JCHO Kumamoto General Hospital, Kumamoto, Japan.\', \'Tokyo Metropolitan Institute for Public Health, Tokyo, Japan.\', \'Department of Refractory Viral Infections, National Center for Global Health and Medicine (NCGM) Research Institute, Tokyo, Japan. hmitsuya@hosp.ncgm.go.jp.\', \'Department of Clinical Sciences, Kumamoto University Hospital, Kumamoto, Japan. hmitsuya@hosp.ncgm.go.jp.\', \'Experimental Retrovirology Section, HIV and AIDS Malignancy Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA. hmitsuya@hosp.ncgm.go.jp.\']
|